Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
about
Poly(Lactic Acid) Nanoparticles Targeting α5β1 Integrin as Vaccine Delivery Vehicle, a Prospective StudyPerspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumorsExploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses In Vivo.Cellobiose-coated poly(lactide-co-glycolide) particles loaded with diphtheria toxoid for per os immunization.Novel antigen delivery systems.Specific and Efficient Uptake of Surfactant-Free Poly(Lactic Acid) Nanovaccine Vehicles by Mucosal Dendritic Cells in Adult Zebrafish after Bath Immersion.Evaluation of polylactic acid nanoparticles safety using Drosophila model.Intranasal delivery of nanoparticle-based vaccines.Current state and challenges in developing oral vaccines.Vaccination against Salmonella Infection: the Mucosal Way.Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-co-glycolic acid) MPs synergistically enhances immune response elicited by intranasally delivered hepatitis B surface antigen.Folic acid conjugation improves the bioavailability and chemosensitizing efficacy of curcumin-encapsulated PLGA-PEG nanoparticles towards paclitaxel chemotherapy.Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models.EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy.Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery.Systematic Overview of Solid Particles and Their Host Responses.Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response.
P2860
Q28555013-64DC16EB-DF20-4BD0-955A-138D1467BFA7Q33712145-9CD5C61E-FB66-4185-B2E1-E54E746B2871Q33855697-C0ECA8FC-ED85-4DA0-955D-D6544150F68CQ35539544-F9F76B64-A4A6-4E3D-9D57-CE2A9188ACF1Q35947894-40526F22-D573-4A05-89FC-21C926E84990Q37667212-2230225A-256A-4FD4-B684-6117E8508610Q38775855-E70E7E37-3446-488B-95A8-4FD3D5C2524DQ39113247-83C5F57C-7741-4167-AC39-6DCE9E70432BQ39259629-8C2BB95E-8352-44A7-A27F-46EA693112BBQ39373957-4F05A2E7-273D-45C3-BBAA-04B4913D65B5Q41225913-191C0BFD-A3FD-4C25-861A-619D96C5EEACQ47106467-DE16A9D7-631D-41A3-A81D-A36F75ED6DADQ47721500-6AC3F17D-FFB3-4CC0-AAC5-92696AFB914FQ48625450-C0D8D3B9-8FE4-45BD-89D1-FD17139A55CCQ48938733-B9E4CFB3-BD8A-445B-B364-B979B70C4AAEQ55216329-D73A2AE4-D358-4A50-AE19-2B67EF817854Q55473113-CA3743A2-EE53-4FB6-9C38-791AEB728A6B
P2860
Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Poly(lactic acid) and poly(lac ...... latforms for vaccine delivery.
@ast
Poly(lactic acid) and poly(lac ...... latforms for vaccine delivery.
@en
type
label
Poly(lactic acid) and poly(lac ...... latforms for vaccine delivery.
@ast
Poly(lactic acid) and poly(lac ...... latforms for vaccine delivery.
@en
prefLabel
Poly(lactic acid) and poly(lac ...... latforms for vaccine delivery.
@ast
Poly(lactic acid) and poly(lac ...... latforms for vaccine delivery.
@en
P2093
P2860
P356
P1433
P1476
Poly(lactic acid) and poly(lac ...... latforms for vaccine delivery.
@en
P2093
Bernard Verrier
Julien Rességuier
Morgane Berthet
Nadège Handké
Sophie Legaz
Stéphane Paul
Vincent Pavot
P2860
P304
P356
10.2217/NNM.14.156
P577
2014-12-01T00:00:00Z